Disseminated intravascular coagulation induced by the combination therapy of encorafenib and binimetinib in a melanoma case

J Dermatol. 2024 Jun;51(6):e218-e219. doi: 10.1111/1346-8138.17124. Epub 2024 Jan 31.

Authors

Sayuka Komatsu¹, Kohei Horimoto¹, Junji Kato¹, Sayuri Sato¹, Eri Kobayashi¹, Iemitsu Matsuda¹, Kohichi Takada², Hisashi Uhara¹

Affiliations

¹ Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
² Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan.

PMID: 38293725
DOI: 10.1111/1346-8138.17124

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols* / adverse effects
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
Benzimidazoles* / administration & dosage
Benzimidazoles* / adverse effects
Carbamates* / adverse effects
Disseminated Intravascular Coagulation* / chemically induced
Disseminated Intravascular Coagulation* / diagnosis
Disseminated Intravascular Coagulation* / drug therapy
Disseminated Intravascular Coagulation* / etiology
Female
Humans
Male
Melanoma* / drug therapy
Skin Neoplasms* / drug therapy
Skin Neoplasms* / pathology
Sulfonamides* / administration & dosage
Sulfonamides* / adverse effects

Substances

encorafenib
Sulfonamides
Carbamates
binimetinib
Benzimidazoles